Keyphrases
Hazard Ratio
100%
National Cohort Study
100%
Comorbidity
100%
Renal Cell Carcinoma
100%
Charlson Comorbidity Index
83%
Survival Rate
33%
5-year Survival
33%
Patient Survival
33%
Denmark
16%
Nationwide Registers
16%
Dementia
16%
Cancer Diagnosis
16%
Increased Mortality
16%
Liver Disease
16%
Young Patients
16%
Older Patients
16%
High Mortality Rate
16%
Comorbid Diseases
16%
Register-based Cohort
16%
Medicine and Dentistry
Cohort Analysis
100%
Hazard Ratio
100%
Clear Cell Renal Cell Carcinoma
100%
Charlson Comorbidity Index
83%
Survival Rate
33%
Disease
16%
Mortality Rate
16%
Liver Disease
16%
Overall Survival
16%
Cancer Diagnosis
16%
Biochemistry, Genetics and Molecular Biology
Cohort Study
100%
Comorbidity
100%
Survival Rate
18%
Mortality Rate
9%
Overall Survival
9%
Immunology and Microbiology
Comorbidity
100%
Carcinoma Cell
100%
Survival Rate
18%
Overall Survival
9%
Mortality Rate
9%